Research Topics
Species | Borwin BandelowSummaryCountry: Germany Publications
| Collaborators
|
Detail Information
Publications
Early traumatic life events, parental rearing styles, family history of mental disorders, and birth risk factors in patients with social anxiety disorderBorwin Bandelow
Dept of Psychiatry and Psychotherapy, The University of Göttingen, Von Siebold Str 5, 37075 Gottingen, Germany
Eur Arch Psychiatry Clin Neurosci 254:397-405. 2004..Childhood traumatic experiences, rearing styles, familial mental disorders and birth risk factors have been associated with the development of social anxiety disorder...
Combined effects of exonic polymorphisms in CRHR1 and AVPR1B genes in a case/control study for panic disorderMartin E Keck
Max Planck Institute of Psychiatry, Munich, Germany
Am J Med Genet B Neuropsychiatr Genet 147:1196-204. 2008..These data suggest that polymorphisms in the AVPR1B and the CRHR1 genes alter the susceptibility to panic disorder...- Early traumatic life events, parental attitudes, family history, and birth risk factors in patients with depressive disorder and healthy controlsBorwin Bandelow
Department of Psychiatry and Psychotherapy, University of Gottingen, Gottingen, Germany
Int J Psychiatry Clin Pract 17:56-63. 2013..Only few studies have compared the frequency of traumatic life events during childhood in inpatients with depression with a healthy control group... 
Posttraumatic stress disorder (PTSD) in the German Armed Forces: a retrospective study in inpatients of a German army hospitalBorwin Bandelow
Department of Psychiatry and Psychotherapy, University of Gottingen, Von Siebold Str 5, 37075, Gottingen, Germany
Eur Arch Psychiatry Clin Neurosci 262:459-67. 2012..8% vs. 5.17%). A careful psychiatric screening before recruitment might help to identify persons at risk of PTSD...- World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revisionBorwin Bandelow
Department of Psychiatry and Psychotherapy, University of Gottingen, Gottingen, Germany
World J Biol Psychiatry 9:248-312. 2008.... - The medical treatment of obsessive-compulsive disorder and anxietyBorwin Bandelow
Department of Psychiatry and Psychotherapy, University of Gottingen, Germany
CNS Spectr 13:37-46. 2008..Cognitive-behavioral therapy has been sufficiently investigated in controlled studies of OCD and anxiety disorders and is recommended alone or in combination with the above medications... - Borderline personality disorder: a dysregulation of the endogenous opioid system?Borwin Bandelow
Department of Psychiatry and Psychotherapy, University of Gottingen, Gottingen, Germany
Psychol Rev 117:623-36. 2010..An understanding of the neurobiology of BPD may help in developing new treatments for patients with this severe disorder... - What is the threshold for symptomatic response and remission for major depressive disorder, panic disorder, social anxiety disorder, and generalized anxiety disorder?Borwin Bandelow
Department of Psychiatry and Psychotherapy, University of Gottingen, Gottingen, Germany
J Clin Psychiatry 67:1428-34. 2006..We also sought to compare the standardized effect sizes of escitalopram for these 4 psychiatric disorders... - Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary careBorwin Bandelow
Department of Psychiatry and Psychotherapy, University of Gottingen, Gottingen, Germany
Int J Psychiatry Clin Pract 16:77-84. 2012..Anxiety disorders are frequently under-diagnosed conditions in primary care, although they can be managed effectively by general practitioners... - Early traumatic life events, parental attitudes, family history, and birth risk factors in patients with borderline personality disorder and healthy controlsBorwin Bandelow
Department of Psychiatry and Psychotherapy, University of Gottingen, Von Siebold Str 5, D 37075, Gottingen, Germany
Psychiatry Res 134:169-79. 2005..The present data support the hypothesis that the etiology of BPD is multifactorial and that familial psychiatric disorders and sexual abuse are contributing factors... - A randomized, controlled trial of aerobic exercise in combination with paroxetine in the treatment of panic disorderDirk Wedekind
Department of Psychiatry and Psychotherapy, University of Goettingen, Goettingen, Germany
World J Biol Psychiatry 11:904-13. 2010..Regular aerobic exercise (running) has been shown to be superior to a pill placebo in the treatment of panic disorder. Combined drug and exercise treatment has not been investigated in randomized controlled studies to date... - The quantification inventory for somatoform syndromes (QUISS): a novel instrument for the assessment of severityDirk Wedekind
Department of Psychiatry, University of Gottingen, Gottingen, Germany
Eur Arch Psychiatry Clin Neurosci 257:153-63. 2007..Characteristic cognitive and behavioural domains, representing severity are not incorporated in the existing scales. Results with the novel quantification inventory for somatoform syndromes (QUISS) are presented in this paper... - Panic disorder during pregnancy and postpartum periodBorwin Bandelow
Department of Psychiatry and Psychotherapy, University of Gottingen, Germany
Eur Psychiatry 21:495-500. 2006..Earlier studies on the influence of pregnancy and postpartum period on the course of panic disorder have been inconsistent. The present study aims to quantify panic manifestations in these periods in large sample of women... - Meta-analysis of randomized controlled comparisons of psychopharmacological and psychological treatments for anxiety disordersBorwin Bandelow
Department of Psychiatry and Psychotherapy, The University of Göttingen, Gottingen, Germany
World J Biol Psychiatry 8:175-87. 2007..We performed a meta-analysis, which only included studies using a direct comparison of pharmacological, psychological, or combined treatments... - Early traumatic life events, parental attitudes, family history, and birth risk factors in patients with panic disorderBorwin Bandelow
Department of Psychiatry and Psychotherapy, , , Germany
Compr Psychiatry 43:269-78. 2002..Owing to the retrospective nature of the data, the results have to be interpreted with caution... - Extended-release quetiapine fumarate (quetiapine XR): a once-daily monotherapy effective in generalized anxiety disorder. Data from a randomized, double-blind, placebo- and active-controlled studyBorwin Bandelow
Department of Psychiatry and Psychotherapy, University of Goettingen, Germany
Int J Neuropsychopharmacol 13:305-20. 2010..8%, 150 mg, 5.0%; placebo, 1.8%; and paroxetine, 8.4%. Once-daily quetiapine XR is an effective and generally well-tolerated treatment for patients with GAD, with symptom improvement seen as early as day 4... - World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and posttraumatic stress disordersBorwin Bandelow
Department of Psychiatry and Psychotherapy, University of Gottingen, Germany
World J Biol Psychiatry 3:171-99. 2002..For social phobia, SSRIs are recommended for the first line, and MAOIs, moclobemide and benzodiazepines as second line. Obsessive-compulsive disorder is best treated with SSRIs or clomipramine... - Defining response and remission in anxiety disorders: toward an integrated approachBorwin Bandelow
Department of Psychiatry and Psychotherapy, University of Gottingen, Gottingen, Germany
CNS Spectr 11:21-8. 2006.... - Insertion/deletion polymorphism in the gene for angiotensin converting enzyme (ACE) in panic disorder: A gender-specific effect?Borwin Bandelow
Department of Psychiatry and Psychotherapy, University of Gottingen, Gottingen, Germany
World J Biol Psychiatry 11:66-70. 2010..0195), respectively, was observed. The present results provide further support for a potentially male-specific role of the less active ACE I allele in the pathogenesis of panic disorder, possibly by altering substance P levels... - Pregabalin for the treatment of generalized anxiety disorder: a novel pharmacologic interventionBorwin Bandelow
University of Gottingen, Department of Psychiatry and Psychotherapy, Von Siebold Str 5, D 37075 Gottingen, Germany
Expert Rev Neurother 7:769-81. 2007..Clinicians may consider the use of pregabalin in lieu of benzodiazepines as an alternative therapy for their patients with GAD... - Escitalopram in the treatment of anxiety symptoms associated with depressionBorwin Bandelow
Department of Psychiatry and Psychotherapy, University of Gottingen, Gottingen, Germany
Depress Anxiety 24:53-61. 2007..Escitalopram was significantly more effective compared to placebo in treating both anxiety symptoms and the entire depression in the total depressive population, as well as in depressive patients with a high degree of anxiety... - Neuroimaging in anxiety disordersKirsten Engel
Department of Psychiatry and Psychotherapy, Anxiety Research Unit, University of Goettingen, Von Siebold Strasse 5, 37075 Goettingen, Germany
J Neural Transm 116:703-16. 2009..An overview of neuroimaging investigations in anxiety disorders is given after a brief summary of results from healthy volunteers. Concluding implications for future research are made by the authors... - Sertraline versus paroxetine in the treatment of panic disorder: an acute, double-blind noninferiority comparisonBorwin Bandelow
Department of Psychiatry and Psychotherapy, University of Gottingen, Von Siebold Strasse 5, D 37505 Göttingen, Germany
J Clin Psychiatry 65:405-13. 2004..The purpose of this study was to compare sertraline and paroxetine in the acute treatment of panic disorder... - Attachment style, anxiety coping, and personality-styles in withdrawn alcohol addicted inpatientsDirk Wedekind
Department of Psychiatry and Psychotherapy, University of Gottingen, Von Siebold Strasse 5, 37075, Goettingen, Germany
Subst Abuse Treat Prev Policy 8:1. 2013.... - Treatment-resistant panic disorderBorwin Bandelow
Department of Psychiatry and Psychotherapy, University of Gottingen, Germany
CNS Spectr 9:725-39. 2004..According to existing studies, a combination of pharmacologic treatment with cognitive-behavioral therapy can be recommended... - "As needed" pharmacotherapy combined with stimulus control treatment in chronic insomnia--assessment of a novel intervention strategy in a primary care settingGoran Hajak
Department of Psychiatry and Psychotherapy, University of Regensburg, Germany
Ann Clin Psychiatry 14:1-7. 2002..Further research is warranted on the contributions of both treatment components to effectiveness and on the efficacy and safety issues of long-term use... - WCA recommendations for the long-term treatment of obsessive-compulsive disorder in adultsJohn H Greist
Healthcare Technology Systems, Inc, Madison, Wisconsin 53717, USA
CNS Spectr 8:7-16. 2003..Further, pharmacotherapy for a minimum of 1-2 years is recommended before very gradual withdrawal may be considered... - WCA recommendations for the long-term treatment of panic disorderMark H Pollack
Division of Psychiatry, Huddinge University Hospital, Stockholm, Sweden
CNS Spectr 8:17-30. 2003..Long-term efficacy and ease of use are important considerations in treatment selection, as maintenance treatment is recommended for at least 12-24 months, and in some cases, indefinitely... - WCA recommendations for the long-term treatment of generalized anxiety disorderChrister Allgulander
Department of Psychiatry, Harvard University School of Medicine, Boston, Massachusetts, USA
CNS Spectr 8:53-61. 2003..Treatment gains after a 12-week course of CBT may be maintained for up to 1 year. Currently, no guidelines exist for the long-term treatment of GAD... - Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for PsychopharmacologyDavid S Baldwin
Division of Clinical Neurosciences, University of Southampton, Southampton, UK
J Psychopharmacol 19:567-96. 2005..The guidelines cover the diagnosis of anxiety disorders and key steps in clinical management, including acute treatment, relapse prevention and approaches for patients who do not respond to first-line treatments... - WCA recommendations for the long-term treatment of social phobiaMichael Van Ameringen
Department of Psychiatry and Behavioral Neurosciences, McMaster University, Hamilton, Ontario, Canada
CNS Spectr 8:40-52. 2003..In light of the chronicity and disability associated with social phobia, as well as the high relapse rate after short-term therapy, it is recommended that effective treatment be continued for at least 12 months... - WCA Recommendations for the long-term treatment of posttraumatic stress disorderDan J Stein
Medical Research Council Research Unit on Anxiety Disorder, University of Stellenbosch, Cape Town, Tygerberg, South Africa
CNS Spectr 8:31-9. 2003..Only SSRIs have been proven effective and safe in long-term randomized controlled trials. Current guidelines from the Expert Consensus Panel for PTSD recommend treatment of chronic PTSD for a minimum of 12-24 months... - Which factors predict placebo response in anxiety disorders and major depression? An analysis of placebo-controlled studies of escitalopramDan J Stein
Department of Psychiatry, University of Cape Town, South Africa
J Clin Psychiatry 67:1741-6. 2006.... - Assessing the severity of panic disorder and agoraphobia: validity, reliability and objectivity of the Turkish translation of the Panic and Agoraphobia Scale (P&A)Umit Tural
School of Medicine, Dokuz Eylul University, Izmir, Turkey
J Anxiety Disord 16:331-40. 2002..88 and .86, respectively. The Turkish version of the P&A has yielded good psychometric properties and was found to be a reliable instrument for assessing severity in panic disorder... - Chromosome 4q31-34 panic disorder risk locus: association of neuropeptide Y Y5 receptor variantsKatharina Domschke
Department of Psychiatry, University of Muenster, Muenster, Germany
Am J Med Genet B Neuropsychiatr Genet 147:510-6. 2008..However, in order to allow for conclusive evaluation of the present finding and to exclude a false positive result, further studies in larger, independent, preferably family based samples are warranted...